Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.creator | Fernandez-Robredo, P. (Patricia) | - |
dc.creator | Recalde, S. (Sergio) | - |
dc.creator | Moreno-Orduña, M. (Maite) | - |
dc.creator | Garcia-Garcia, L. (Laura) | - |
dc.creator | Zarranz-Ventura, J. (Javier) | - |
dc.creator | Garcia-Layana, A. (Alfredo) | - |
dc.date.accessioned | 2014-08-23T10:58:17Z | - |
dc.date.available | 2014-08-23T10:58:17Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Fernández-Robredo P, Recalde S, Moreno-Orduña M, García-García L, Zarranz-Ventura J, García-Layana A. Azithromycin reduces inflammation in a rat model of acute conjunctivitis. Mol Vis. 2013;19:153-165 | es_ES |
dc.identifier.issn | 1090-0535 | - |
dc.identifier.uri | https://hdl.handle.net/10171/36369 | - |
dc.description.abstract | PURPOSE: Macrolide antibiotics are known to have various anti-inflammatory effects in addition to their antimicrobial activity, but the mechanisms are still unclear. The effect of azithromycin on inflammatory molecules in the lipopolysaccharide-induced rat conjunctivitis model was investigated. METHODS: Twenty-four Wistar rats were divided into two groups receiving topical ocular azithromycin (15 mg/g) or vehicle. In total, six doses (25 µl) were administered as one dose twice a day for three days before subconjunctival lipopolysaccharide injection (3 mg/ml). Before the rats were euthanized, mucus secretion, conjunctival and palpebral edema and redness were evaluated. Real-time polymerase chain reaction was used to determine gene expression for interleukin-6, cyclooxygenase-2, tumor necrosis factor-α, matrix metalloproteinase (MMP)-2, and MMP-9. Interleukin-6 was determined with enzyme-linked immunosorbent assay, nuclear factor-kappa B with western blot, and MMP-2 activity with gelatin zymogram. Four eyes per group were processed for histology and subsequent periodic acid-Schiff staining and CD68 for immunofluorescence. The Student t test or the Wilcoxon test for independent samples was applied (SPSS v.15.0). RESULTS: Azithromycin-treated animals showed a significant reduction in all clinical signs (p<0.05) compared to controls. Interleukin-6 (p<0.05), nuclear factor-kappa B protein expression (p<0.01), and MMP-2 activity (p<0.05) in conjunctival homogenates were significantly reduced compared with the control animals. MMP-2 gene expression showed a tendency to decrease in the azithromycin group (p=0.063). Mucus secretion by goblet cells and the macrophage count in conjunctival tissue were also decreased in the azithromycin group (p<0.05). CONCLUSIONS: These results suggest that azithromycin administration ameliorates induced inflammation effects in a rat model of acute conjunctivitis. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Molecular Vision | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Azithromycin | es_ES |
dc.subject | Rats | es_ES |
dc.subject | Conjunctivitis | es_ES |
dc.subject | Anti-Inflammatory Agents, Non-Steroidal | es_ES |
dc.title | Azithromycin reduces inflammation in a rat model of acute conjunctivitis | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | http://www.molvis.org/molvis/v19/153/ | es_ES |
Ficheros en este ítem:
Estadísticas e impacto
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.